11/13/2024
2:30 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
7:30 AM | Cocrystal Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
8:10 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
Hassan Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
Japour Anthony J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
Martin James Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
PFENNIGER RICHARD C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
Lee Sam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
Rubin Steven D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:06 PM | Cocrystal Pharma (Issuer)
FROST PHILLIP MD ET AL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:06 PM | Cocrystal Pharma (Issuer)
Kornberg Roger D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
4:02 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
7:00 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
7:00 AM | Cocrystal Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
7:15 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
8:00 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
7:30 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
7:00 AM | Cocrystal Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
7:15 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
7:00 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
4:12 PM | Cocrystal Pharma (Filer)
| Form PRE 14A | |
04/17/2024
4:00 PM | Cocrystal Pharma (Filer)
| Form 10-K/A | |
03/28/2024
7:00 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
7:01 AM | Cocrystal Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/19/2024
7:30 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:00 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:01 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
8:53 AM | Cocrystal Pharma (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
12/21/2023
4:00 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
